| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |